Tela Bio Inc Reports Results For The Quarter Ended In June: Earnings Summary

TELA Bio

09/08/2023 22:02

* TELA Bio Inc  TELA.OQ  reported a quarterly adjusted loss
of 46
cents​​ per share for the quarter ended in June. The mean
expectation of five analysts for the quarter was for a loss
of 53 cents per share.
    * Revenue rose 39.3% to $14.49 million from a year ago;
analysts
expected $14.40 million. 
    * TELA Bio Inc's reported EPS for the quarter was a loss
of 46
cents​.
    * The mean earnings estimate of analysts had fallen by
about 2.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * TELA Bio Inc shares had fallen by 9.1% this quarter and
lost 19.9% so far this year.
    * The company reported a quarterly loss of $10.79 million.
    * Wall Street's median 12-month price target for TELA Bio
Inc is
$18.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 9 at 09:02 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.53          -0.46          Beat
 Mar. 31 2023      -0.56          -0.63          Missed
 Dec. 31 2022      -0.55          -0.52          Beat
 Sep. 30 2022      -0.63          -0.64          Missed